Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinogen activation by sulfate conjugate formation

C J Michejda1, M B Kroeger Koepke

  • 1Molecular Aspects of Drug Design Section, NCI-Frederick Cancer Research and Development Center, Maryland 21702.

Advances in Pharmacology (San Diego, Calif.)
|January 1, 1994
PubMed
Summary

Sulfotransferase conjugation activates xenobiotics to modify cellular macromolecules. However, metabolic switching due to various factors means in vitro sulfation doesn't always predict in vivo activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VIP-ellipticine derivatives inhibit the growth of breast cancer cells.

Life sciences·2002
Same author

Bisimidazoacridones induce a potent cytostatic effect in colon tumor cells that sensitizes them to killing by UCN-01.

Cancer chemotherapy and pharmacology·2001
Same author

Monte Carlo calculations on HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor 8-Cl TIBO: contribution of the L100I and Y181C variants to protein stability and biological activity.

Protein engineering·2000
Same author

Inhibition of G-protein-coupled receptor function by disruption of transmembrane domain interactions.

The Journal of biological chemistry·1999
Same author

Bisimidazoacridones: effect of molecular environment on conformation and photophysical properties.

Photochemistry and photobiology·1999
Same author

Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method.

Journal of medicinal chemistry·1998

Area of Science:

  • Biochemistry
  • Pharmacology
  • Toxicology

Background:

  • Sulfotransferase conjugation is a key metabolic pathway for xenobiotics.
  • This process can transform xenobiotics into reactive species capable of modifying cellular macromolecules.

Purpose of the Study:

  • To investigate the role and limitations of sulfotransferase conjugation in xenobiotic metabolism.
  • To highlight the phenomenon of metabolic switching and its implications for predicting xenobiotic activation.

Main Methods:

  • Review of existing data on sulfotransferase conjugation.
  • Analysis of factors influencing xenobiotic metabolic pathways.
  • Comparison of in vitro and in vivo metabolic outcomes.

Main Results:

Related Experiment Videos

  • Sulfation is one of several metabolic pathways available to xenobiotics.
  • Metabolic switching can be influenced by substrate concentration, cofactor availability, and competing metabolic reactions (Phase-I/Phase-II).
  • In vitro sulfation does not always correlate with in vivo activation, and analogies can be misleading.

Conclusions:

  • Sulfation is an important mechanism for activating certain chemicals.
  • Metabolic context and competing pathways significantly impact the ultimate fate of xenobiotics.
  • Predicting xenobiotic activation requires careful consideration of multiple factors beyond simple in vitro assays.